Abstract
I have spent a 33-year career studying respiratory RNA viruses, devising vaccine approaches against them, and unravelling the human immune response to these viruses and vaccines, as well as promoting policies to minimise their effects. Over the past 10 weeks, I and many others have been in the thick of explaining what we know about coronaviruses and other respiratory viruses, and extrapolating this knowledge to understand severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to many health-care providers, organisations, media, and lay people.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
